"Several preclinical and translational data studies suggest potential causative effects on bone health. One study with GLP-1 ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

The World Health Organization (WHO) has added Novo Nordisk’s Ozempic and Eli Lilly’s Mounjaro to its Model List of Essential ...

Over the last six years, three GLP-1 drugs have been approved for children aged 10 and older with Type 2 diabetes. | Over the ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat healthily and exercise regularly.

People with a common personality trait practiced by as many as one in five Americans may see fewer lasting results from GLP-1 ...

The Food and Drug Administration is cracking down on ingredients from potentially from unverified foreign sources and that ...

People with obesity and diabetes who undergo bariatric surgery face a significantly lower risk for several adverse health outcomes vs. those treated with GLP-1s, new data show.“Surgery should not be ...

Eli Lilly's Mounjaro helped children and adolescents aged 10 to 17 years with type 2 diabetes manage their blood sugar better ...

Misleading promotions of GLP-1 and compounded semaglutide products are drawing renewed regulatory scrutiny over risk ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat ...

Insurance coverage for GLP-1 agonists when used for weight loss varies widely, explains GoodRX, a platform for medication savings. But these medications are often covered when prescribed for their ...